Roberta Turiello
@rturiello.bsky.social
🥼 Post-doctoral Researcher at the Telethon Institute of Genetics and Medicine, NA🇮🇹
Previously Postdoc at IEO, UKB, Bonn 🇩🇪
🔬Genomic and Experimental Medicine |Rare cancers | Rare genetic diseases
🛸 Spatial Biology enthusiast
📚 Bookworm
🇮🇹 Padula, SA
Previously Postdoc at IEO, UKB, Bonn 🇩🇪
🔬Genomic and Experimental Medicine |Rare cancers | Rare genetic diseases
🛸 Spatial Biology enthusiast
📚 Bookworm
🇮🇹 Padula, SA
🚨 New Paper in European Journal of Immunology!
We show that NKG7 is a robust marker of cytotoxicity, outperforming GZMB and PRF1 across immune cell types and tissues!
Thanks to all co-authors, @nsssusanna.bsky.social, @M.Hoelzel & @eomesodermin.bsky.social
📖 onlinelibrary.wiley.com/doi/10.1002/...
We show that NKG7 is a robust marker of cytotoxicity, outperforming GZMB and PRF1 across immune cell types and tissues!
Thanks to all co-authors, @nsssusanna.bsky.social, @M.Hoelzel & @eomesodermin.bsky.social
📖 onlinelibrary.wiley.com/doi/10.1002/...
NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor Microenvironment
Cytotoxicity-associated genes exhibit heterogeneity at the cellular and tissue levels (left). NKG7 gene expression is strongly associated with a cytotoxic gene signature (middle). NKG7 expression is ...
onlinelibrary.wiley.com
June 24, 2025 at 1:59 PM
🚨 New Paper in European Journal of Immunology!
We show that NKG7 is a robust marker of cytotoxicity, outperforming GZMB and PRF1 across immune cell types and tissues!
Thanks to all co-authors, @nsssusanna.bsky.social, @M.Hoelzel & @eomesodermin.bsky.social
📖 onlinelibrary.wiley.com/doi/10.1002/...
We show that NKG7 is a robust marker of cytotoxicity, outperforming GZMB and PRF1 across immune cell types and tissues!
Thanks to all co-authors, @nsssusanna.bsky.social, @M.Hoelzel & @eomesodermin.bsky.social
📖 onlinelibrary.wiley.com/doi/10.1002/...
Reposted by Roberta Turiello
NKG7 is a stable marker of cytotoxicity across immune contexts and within the tumor microenvironment
www.biorxiv.org/content/10.1...
@eomesodermin.bsky.social @nsssusanna.bsky.social @rturiello.bsky.social
www.biorxiv.org/content/10.1...
@eomesodermin.bsky.social @nsssusanna.bsky.social @rturiello.bsky.social
February 9, 2025 at 9:25 PM
NKG7 is a stable marker of cytotoxicity across immune contexts and within the tumor microenvironment
www.biorxiv.org/content/10.1...
@eomesodermin.bsky.social @nsssusanna.bsky.social @rturiello.bsky.social
www.biorxiv.org/content/10.1...
@eomesodermin.bsky.social @nsssusanna.bsky.social @rturiello.bsky.social
The inaugural conference of the European Society for Spatial Biology (#ESSB) has kicked off today in Berlin!
#IEO is here and represented by me and our PhD students Tim and Lukas. Come say hi, we got cool stories to share!
🟤 Interested in melanoma? Find me at poster #171 or shoot me a message!
#IEO is here and represented by me and our PhD students Tim and Lukas. Come say hi, we got cool stories to share!
🟤 Interested in melanoma? Find me at poster #171 or shoot me a message!
December 12, 2024 at 3:05 PM
The inaugural conference of the European Society for Spatial Biology (#ESSB) has kicked off today in Berlin!
#IEO is here and represented by me and our PhD students Tim and Lukas. Come say hi, we got cool stories to share!
🟤 Interested in melanoma? Find me at poster #171 or shoot me a message!
#IEO is here and represented by me and our PhD students Tim and Lukas. Come say hi, we got cool stories to share!
🟤 Interested in melanoma? Find me at poster #171 or shoot me a message!
The #MelanomaBridge was the first conference I attended, after starting my PhD in 2018. This year, I had the privilege of returning as a postdoc, showing some of my data.
3 days of inspiring talks and thought-provoking debates. Heading back to Bonn now, with new ideas and inspiration for my project
3 days of inspiring talks and thought-provoking debates. Heading back to Bonn now, with new ideas and inspiration for my project
December 8, 2024 at 8:02 PM
The #MelanomaBridge was the first conference I attended, after starting my PhD in 2018. This year, I had the privilege of returning as a postdoc, showing some of my data.
3 days of inspiring talks and thought-provoking debates. Heading back to Bonn now, with new ideas and inspiration for my project
3 days of inspiring talks and thought-provoking debates. Heading back to Bonn now, with new ideas and inspiration for my project